select trial glp 1 Cardiac Trials | ~~ Most popular post of #2023 ~~ GLP1 agonism in overweight/obese patients to reduce cardiovascular mortality? This landmark trial SELECT: Glucagon-like peptide-1 receptor agonist

Clinical Medicine: Therapeutics

The company announced yesterday that it has officially begun enrolling participants in a Phase 2 trial of pemvidutide, its GLP-1 and glucagon dual receptor agonist, to evaluate the drug in people with Alcohol Use Disorder, or AUD

Tirzepatide is considered one of the most effective prescription options currently available for weight loss, especially when compared with many older medications and lifestyle-only approaches

too much fiber late can lead to digestive discomfort

Here, inside the large intestine, the fiber meets a whole crew of microbes that can digest the fiber

Such offers are made only pursuant to the formal offering documents for the fund(s) concerned, and describe significant risks and other material information that should be carefully considered before investing